[CONVERTIBLE NOTE PURCHASE among CHINARD BLOODRPORATION and GOLDEN MEDITECHS LIMITEDted September 18, 2012 TABLE OFNTENTS P Section 1 INTERPRETATION 2 Section 2LE AND PURCHASE OF THE NOTES 9 Section 3NDITIONS PRECEDENT TOMPLETION 9 Section 4MPLETION ACTIONS 13 14 16 Section 7NFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS] [Chinard Bloodrporation and Golden Meditechs Limited Jointnferencell to be Held September 19, 2012 at 8:00 a.m. ET / 8:00 p.m. HKT HONG KONG, China, September 18, 2012 Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood banking operator in China and]

[China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013 1Q13 New Subscribers Up 28.3% to 16,460 1Q13 Revenue Up 31.9% YOY to RMB115.3 Million 1Q13 Operating Income Up 44.4% to RMB44.4 Million Conference Call to be Held August 23, 2012 at 8:00 a.m. ET HONG KONG, China, August 22, 2012 — China Cord Blood Corporation]

[Execution Copy SHARE PURCHASE AGREEMENT among CHINA CORD BLOOD CORPORATION and CORDLIFE GROUP LIMITED Dated August 15, 2012 Table of Contents Page Section 1 INTERPRETATION 2 Section 2 sALE AND PURCHASE OF THE SALE SHARES 8 Section 3 CONDITIONS PRECEDENT TO COMPLETION 8 Section 4 COMPLETION ACTIONS 12 14 14 Section 7 CONFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS 15] [EXECUTION COPY th DATED THIS 15 Between CHINA STEM CELLS (SOUTH) COMPANY LIMITED and Cordlife (Hong Kong) Limited SHARES REPURCHASE AGREEMENT relating to the repurchase of 100 ordinary shares in CHINA STEM CELLS (SOUTH) COMPANY LIMITED TABLE OF CONTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 3 2. REPURCHASE OF THE REPURCHASED SHARES 5 3. CONDITIONS 6 4. CONSIDERATION FOR] [China Cord Blood Corporation and Cordlife Group Limited HONG KONG, China, August 15, 2012 -- China Cord Blood Corporation "CCBC's prominent leadership in the industry clearly speaks to its presence in China. In recent years, it has successfully brought the benefits of umbilical cord blood banking to numerous people in multiple regions across China," commented Mr. Jeremy Yee. "CCBC's management]

[Executionpy SHARE PURCHASEREEMENT among CHINARD BLOODRPORATION andRDLIFE LIMITEDted August 15, 2012 Table ofntents Page Section 1 INTERPRETATION 2 Section 2LE AND PURCHASE OF THELE SHARES 8 Section 3NDITIONS PRECEDENT TOMPLETION 8 Section 4MPLETION ACTIONS 12 14 14 Section 7NFIDENTIALITY; RESTRICTION ON ANNOUNCEMENTS] [EXECUTIONPY thTED THIS 15 Between CHINA STEM CELLS (SOUTH)MPANY LIMITED andrdlife (Hong Kong) Limited SHARES REPURCHASEREEMENT relating to the repurchase of 100 ordinary shares in CHINA STEM CELLS (SOUTH)MPANY LIMITED TABLE OFNTENTS CLAUSE HEADING PAGE 1. DEFINITIONS AND INTERPRETATION 3 2. REPURCHASE OF THE REPURCHASED SHARES] [Chinard Bloodrporation andrdlife Limited HONG KONG, China, August 15, 2012 -- Chinard Bloodrporation "CCBC's prominent leadership in the industry clearlyeaks to its presence in China. In recent years, it has successfully brought the benefits of umbilicalrd blood banking to numerous people in multiple regions across China,"mmented Mr. Jeremy Yee. "CCBC's management teamnsistently demonstrates their uniqueility]